Stay Tuned to the LDL Controversy

Debate continues about the role of LDL levels in statin patients.

We know the new thinking is to use target DOSES of statins to reduce CV risk...instead of titrating to a specific LDL goal.

But don't recommend a "fire and forget" approach.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote